This project brief describes PATH's work in the Democratic Republic of Congo to control and treat multidrug-resistant tuberculosis (MDR-TB). The brief outlines a project to train national clinicians to diagnose MDR-TB, strengthen the diagnostic capacities of local laboratories, and mobilize communities to help patients successfully complete treatment. All of this work was made possible with generous funding from the United States Agency for International Development.

Publication date: August 2014

Region: Africa

This project brief explains how PATH worked to improve tuberculosis (TB) data collection methods at the local level in the Democratic Republic of Congo, which led to more timely and accurate reporting of data to national and global stakeholders, allowing officials to have more relevant discussions around TB control. All of this work was made possible with generous funding from the United States Agency for International Development.

Publication date: August 2014

Region: Africa

This report shares highlights of PATH’s use of private donations in 2013. Stories describe how support from donors helped vaccinate children in Laos against Japanese encephalitis, launch a Global Health Innovation Hub, catalyze a diagnostic test for river blindness, and introduce Sayana® Press, a new injectible contraceptive for women.

Publication date: August 2014

Region: Global

Part of series: Reports to contributors

This project brief outlines PATH's work to improve integrated services for tuberculosis (TB) and HIV in various districts throughout Vietnam using a public-private mix model. The brief details how the project was piloted and adapted over time to successfully improve TB and HIV case detection and treatment in the project sites. All of this work was made possible with generous funding from the United States Agency for International Development.

Publication date: August 2014

Region: Asia

This project brief explains the activities and outcomes of PATH's work in the Democratic Republic of Congo to control and treat tuberculosis (TB) and HIV co-infection. By introducing and scaling up a comprehensive package of collaborative interventions, PATH influenced TB-HIV planning at the national level, activities in the field, and community access to integrated TB-HIV services. All of this work was made possible with generous funding from the United States Agency for International Development.

Publication date: August 2014

Region: Africa

This fact sheet provides an overview of PATH's work, global presence, innovation platforms, partners, and funding. It is available in English, French, Russian, and Spanish.

Publication date: July 2014

Region: Global

Artemisinin-based combination therapy is considered the gold standard treatment for malaria, but global demand has often outpaced production, and pricing has been volatile. This fact sheet describes the cross-sector partnership PATH formed to develop a new way to produce high-quality, nonseasonal, and affordable artemisinin to supplement the plant-based supply.

Publication date: July 2014

Region: Global

In 2013, PATH and our partners touched the lives of more than 219 million people with new vaccines and drug treatments, breakthrough health tools, and powerful strategies to change the course of disease. Our 2013 annual report highlights our achievements across five innovation platforms.

Publication date: May 2014

Region: Global

Part of series: Annual reports

Part of the Technology Updates series, this fact sheet describes PATH's work to develop, test, and introduce a low-cost balloon tamponade that can be used in low-resource settings to control postpartum hemorrhage.

Publication date: May 2014

Region: Global

Part of series: Technology Updates

This project brief describes PATH’s work in promoting tuberculosis (TB) control in India by building local and national capacities in advocacy, communication, and social mobilization (ACSM) strategies. This work aimed to improve TB case detection and treatment adherence by training local civil-society members and national-level staff to design and implement ACSM work plans. This project was made possible through support from the United States Agency for International Development.

Publication date: May 2014

Region: Asia

Part of series: Tuberculosis activities in India

Part of the Technology Updates series, this fact sheet describes PATH's work to develop and evaluate the concept of ready-to-use magnesium sulfate (MgSO4) packs that will eliminate dosing calculation and dilution at the time of use.

Publication date: May 2014

Region: Global

Part of series: Technology Updates

This project brief describes PATH’s work in promoting tuberculosis (TB) control in India by contributing to health human resources development throughout the country. With support from the United States Agency for International Development, PATH worked with Initiatives Inc. to assess the state of human resources working in TB-related capacities in India, to analyze the feasibility of integrating the national TB program with the general health system, and to pilot an integrated model of TB programming within the general health system in four districts. The brief outlines lessons learned that can be applied to future health human resources development in TB-related capacities in India and globally.

Publication date: May 2014

Region: Asia

Part of series: Tuberculosis activities in India

Part of the Technology Updates series, this fact sheet describes PATH's work to develop an oxytocin sublingual fast-dissolving tablet presentation that dissolves in less than ten seconds in the patient’s mouth without the need for additional water or diluent. Oxytocin in this type of presentation could potentially increase the reach and efficacy of this lifesaving medication to areas lacking access to skilled health workers, refrigeration, or safe injection equipment.

Publication date: May 2014

Region: Global

Part of series: Technology Updates

This project brief outlines PATH’s work in strengthening national laboratories in India to correctly diagnose tuberculosis (TB), including multidrug-resistant tuberculosis (MDR-TB). In collaboration with FIND, the World Health Organization, and other partners, PATH provided intense technical assistance to India's Revised National TB Control Program to introduce new diagnostic technologies into Indian laboratories, improve biosafety and infrastructure, build nationwide laboratory networks, and strengthen quality assurance. This work was made possible through support from the United States Agency for International Development.

Publication date: May 2014

Region: Asia

Part of series: Tuberculosis activities in India

Part of the Technology Updates series, this fact sheet describes PATH's work in adapting the concept of a dilution bottle to simplify the process of magnesium sulfate administration for the treatment of preeclampsia and eclampsia. A dilution bottle bottle can facilitate the safe calculation of recommended doses by obviating the need to remember complex equations for dilution.

Publication date: May 2014

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH’s work in collaboration with the University of Washington to develop a mobile application for magnesium sulfate administration for the treatment of preeclampsia and eclampsia. The application includes a dosing calculator and a detailed checklist based on World Health Organization protocol and is designed specifically to address the challenges of correctly calculating the dosage.

Publication date: May 2014

Region: Global

Part of series: Technology Updates

This project brief describes one aspect of PATH’s contributions to tuberculosis (TB) control in India. With the support of the United States Agency for International Development, PATH worked with India’s Revised National TB Control Program to implement new national guidelines on airborne infection control in India. Work included developing education materials for health workers and their patients, convening experience-sharing workshops for national TB program staff, and training local engineers and architects to design effective infection-control measures within health facilities.

Publication date: May 2014

Region: Asia

Part of series: Tuberculosis activities in India

This project brief describes PATH’s contributions to developing public-private mix (PPM) approaches to TB control in India. With support from the United States Agency for International Development, PATH supported a PPM pilot project in Andhra Pradesh that aimed to train private chemists in identifying presumed TB cases and referring them to government diagnosis centers, promoting community awareness of TB prevention, and reducing the sale of TB drugs to persons without a prescription. This project provided valuable lessons and insights into applying PPM strategies to future TB control projects in India and elsewhere.

Publication date: May 2014

Region: Asia

Part of series: Tuberculosis activities in India

Part of the Technology Updates series, this fact sheet describes PATH's work to develop a rectally administered magnesium sulfate (MgSO4) formulation that could simplify delivery and improve access to MgSO4 treatment in low-resource settings.

Publication date: May 2014

Region: Global

Part of series: Technology Updates

Severe preeclampsia and eclampsia (PE/E) are among the leading causes of maternal death and disability worldwide. Magnesium sulfate is the treatment recommended by the World Health Organization, but it remains underutilized due to difficult administration. PATH designed a mobile application for dosing and dilution of magnesium sulfate to address the challenges of correctly calculating magnesium sulfate dosage given multiple concentrations and a complex dosing regimen.

Publication date: May 2014

Region: Global